Lactam-Modified AAV Capsids for Targeted Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing adeno-associated virus (AAV) vectors face limitations such as immunogenicity, unselective distribution, and reduced therapeutic index due to broad tropism, necessitating improved methods for modifying capsid proteins to enhance cell-specific transduction and evade the immune system.
Innovation Solution
The modification of AAV vectors involves covalently coupling a lactam group, such as β-lactam, to the amino group of the capsid's lysine residue, incorporating a cell-type specific ligand or steric shielding agent, to create a moiety that maintains vector integrity and reduces immunogenicity while enhancing transduction efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If AAV vectors are used for gene delivery, then transduction efficacy is improved, but immunogenicity increases
Solution Approach 1:
The patent applies chemical modification to change the surface properties of the AAV capsid by covalently coupling compounds with reactive functional groups (such as isothiocyanate, epoxide, or azide groups) to amino acid residues. This chemical parameter change alters the capsid's interaction with the immune system while preserving transduction capability, thereby reducing immunogenicity without sacrificing transduction efficacy.
Solution Approach 2:
The patent creates composite capsid structures by combining the original AAV capsid proteins with chemically coupled compounds bearing specific functional groups. This composite approach allows the retention of the native capsid's transduction properties while adding immunomodulatory characteristics through the coupled compounds.
2Adaptability or versatility
If AAV vectors are administered systemically, then broad tissue distribution is achieved, but cell-specific transduction is reduced
Solution Approach 1:
The patent introduces cell-type specific ligands or blocking compounds onto the capsid surface through covalent coupling, creating localized functional regions that confer specific tissue tropism. This allows the vector to distinguish between different cell types and target only the desired tissue, transforming the originally broad tropism into selective cell-specific transduction.
Solution Approach 2:
The patent uses chemically coupled ligands as intermediary molecules that mediate the interaction between the AAV capsid and specific cell surface receptors. These ligands act as molecular bridges that enable selective binding to target cells while preventing non-specific interactions with other tissues.
3Productivity
If high doses of AAV vectors are used, then therapeutic efficacy is improved, but immune response increases
Solution Approach 1:
The patent performs preliminary chemical modification of the capsid before administration by covalently coupling immunomodulatory compounds. This preliminary action pre-establishes immune evasion properties on the capsid surface, allowing therapeutic efficacy to be achieved at lower doses without triggering strong immune responses that would occur with unmodified high-dose vectors.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified AAV vectors demonstrate improved tissue distribution and transgene expression levels, maintaining infectivity and reducing immunogenicity, thereby addressing the limitations of unmodified vectors.
Implementation Method 1
covalently coupling of at least one compound comprising a lactam (e.g., β-lactam) to at least one amino group of an amino acid residue of the capsid
Data Source
AI summary
The present invention relates to adeno-associated virus (AAV) vectors modified by the covalent coupling of at least one compound comprising a lactam moiety (e.g., β-lactam) to at least one amino group of an amino acid residue of the capsid of the AAV vectors. The AAV vectors are useful in transducing a cell, especially for gene therapy.